Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Tools & Techniques

Tools & Techniques Clinical trials

A Framework for Translation

| Jonathan James

How strong partnerships can drive early-phase clinical trials

Tools & Techniques Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Tools & Techniques Omics

A Microbial Map to Cancer

| Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Tools & Techniques Imaging

Revamping the Digital Interface

| Luke Turner

We sit down with digital pathology advocate David Wilbur to discuss how the advancement of digital interfaces could lead to widespread adoption.

Tools & Techniques Omics

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The application of CRISPR on a genome-wide scale provides a major insight into tumor dependency.

Tools & Techniques Imaging

IVF ID

| Jonathan James

Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.

Tools & Techniques Diagnostics & prognostics

PREDICTive Power

| Jonathan James

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

Tools & Techniques Diagnostics & prognostics

Unlocking Serology’s Secrets

| Jonathan James

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

Tools & Techniques Diagnostics & prognostics

Solving the Big Problems

| Luke Turner

We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives

Tools & Techniques Diagnostics & prognostics

An Inside Look at the CNS

| Danielle Fortuna, Mark Curtis

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register